Heart failure affects more than 1.5 million people in France, resulting in over 70,000 deaths and more than 165,000 hospitalizations each year. Viral and bacterial infections are frequently associated with episodes of acute heart failure in patients with chronic heart failure (CHF). Lower respiratory tract infections, such as influenza and pneumococcus, are common causes of hospitalization for decompensated heart failure, leading to increased morbidity and mortality. Studies have shown that pneumococcal vaccination can reduce the risks of heart attack or stroke in patients with heart failure. However, despite vaccination recommendations, coverage rates remain low, especially for pneumococcus. In this study, we will evaluate the impact of an incentive letter for pneumococcal vaccination on one-year hospitalization rate in patients with heart failure.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
12,000
Incentive letter for pneumococcal vaccination to the patient and to the GP
Montpellier University Hospital
Montpellier, France
1-year Pneumococcus vaccination rate
Time frame: at 1-year
1-year all-cause hospital admission rate
Time frame: at 1-year
1-year specific hospital admission rate
Time frame: at 1-year
1-year all-cause mortality rate
Time frame: at 1-year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.